Sriram Ryali - 10 Jan 2025 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Role
Chief Financial Officer
Signature
/s/ Barbara G. McClung, as attorney-in-fact
Issuer symbol
CRBU
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
4
Filing time
10 Jan 2025, 17:06:04 UTC
Previous filing
10 Jan 2025
Next filing
30 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Award $0 +300,000 $0.000000 300,000 10 Jan 2025 Common Stock 300,000 $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on January 2, 2026, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following January 2, 2026), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.